Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 87 entries
Sorted by: Best Match Show Resources per page
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.

PPAR research

Barrera G, Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Dianzani MU, Ferretti C.
PMID: 18615196
PPAR Res. 2008;2008:524671. doi: 10.1155/2008/524671.

Peroxisome proliferators-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. The three PPAR isoforms (alpha, gamma and beta/delta) have been found to play a pleiotropic role in cell fat metabolism. Furthermore, in recent...

Cite
Barrera G, Toaldo C, Pizzimenti S, et al. The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Res. 2008;2008:524671doi: 10.1155/2008/524671.
Barrera, G., Toaldo, C., Pizzimenti, S., Cerbone, A., Pettazzoni, P., Dianzani, M. U., & Ferretti, C. (2008). The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR research, 2008524671. https://doi.org/10.1155/2008/524671
Barrera, Giuseppina, et al. "The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products." PPAR research vol. 2008 (2008): 524671. doi: https://doi.org/10.1155/2008/524671
Barrera G, Toaldo C, Pizzimenti S, Cerbone A, Pettazzoni P, Dianzani MU, Ferretti C. The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Res. 2008;2008:524671. doi: 10.1155/2008/524671. PMID: 18615196; PMCID: PMC2443425.
Copy Download .nbib Format: NLM
What is the practical significance of antibodies to interferons?.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Dianzani F, Antonelli G.
PMID: 18020559
BioDrugs. 1998 Mar;9(3):187-95. doi: 10.2165/00063030-199809030-00002.

Interferons are generally recognised as the treatment of choice in some infectious diseases, such as chronic hepatitis B and C. Since the early clinical trials it was documented that the therapeutic use of interferons could be complicated by the...

Cite
Dianzani F, Antonelli G. What is the practical significance of antibodies to interferons?. BioDrugs. 1998;9(3):187-95doi: 10.2165/00063030-199809030-00002.
Dianzani, F., & Antonelli, G. (1998). What is the practical significance of antibodies to interferons?. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 9(3), 187-95. https://doi.org/10.2165/00063030-199809030-00002
Dianzani, F, and Antonelli, G. "What is the practical significance of antibodies to interferons?." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 9,3 (1998): 187-95. doi: https://doi.org/10.2165/00063030-199809030-00002
Dianzani F, Antonelli G. What is the practical significance of antibodies to interferons?. BioDrugs. 1998 Mar;9(3):187-95. doi: 10.2165/00063030-199809030-00002. PMID: 18020559.
Copy Download .nbib Format: NLM
Advances in neuroimmunology: from bench to bedside.

Autoimmune diseases

Comi C, Dianzani U, Martinelli Boneschi F, Menkes DL.
PMID: 24575299
Autoimmune Dis. 2014;2014:812847. doi: 10.1155/2014/812847. Epub 2014 Jan 19.

No abstract available.

Cite
Comi C, Dianzani U, Martinelli Boneschi F, et al. Advances in neuroimmunology: from bench to bedside. Autoimmune Dis. 2014;2014:812847doi: 10.1155/2014/812847.
Comi, C., Dianzani, U., Martinelli Boneschi, F., & Menkes, D. L. (2014). Advances in neuroimmunology: from bench to bedside. Autoimmune diseases, 2014812847. https://doi.org/10.1155/2014/812847
Comi, Cristoforo, et al. "Advances in neuroimmunology: from bench to bedside." Autoimmune diseases vol. 2014 (2014): 812847. doi: https://doi.org/10.1155/2014/812847
Comi C, Dianzani U, Martinelli Boneschi F, Menkes DL. Advances in neuroimmunology: from bench to bedside. Autoimmune Dis. 2014;2014:812847. doi: 10.1155/2014/812847. Epub 2014 Jan 19. PMID: 24575299; PMCID: PMC3915761.
Copy Download .nbib Format: NLM
AIDS and HIV Infection after Thirty Years.

AIDS research and treatment

Ippolito G, Levy JA, Sonnerborg A, Mugusi F, Dianzani F.
PMID: 23365727
AIDS Res Treat. 2013;2013:731983. doi: 10.1155/2013/731983. Epub 2013 Jan 10.

No abstract available.

Cite
Ippolito G, Levy JA, Sonnerborg A, et al. AIDS and HIV Infection after Thirty Years. AIDS Res Treat. 2013;2013:731983doi: 10.1155/2013/731983.
Ippolito, G., Levy, J. A., Sonnerborg, A., Mugusi, F., & Dianzani, F. (2013). AIDS and HIV Infection after Thirty Years. AIDS research and treatment, 2013731983. https://doi.org/10.1155/2013/731983
Ippolito, Giuseppe, et al. "AIDS and HIV Infection after Thirty Years." AIDS research and treatment vol. 2013 (2013): 731983. doi: https://doi.org/10.1155/2013/731983
Ippolito G, Levy JA, Sonnerborg A, Mugusi F, Dianzani F. AIDS and HIV Infection after Thirty Years. AIDS Res Treat. 2013;2013:731983. doi: 10.1155/2013/731983. Epub 2013 Jan 10. PMID: 23365727; PMCID: PMC3556433.
Copy Download .nbib Format: NLM
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes.

Journal of extracellular vesicles

Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI, Lötvall J.
PMID: 24223256
J Extracell Vesicles. 2013 Sep 12;2. doi: 10.3402/jev.v2i0.20677. eCollection 2013.

INTRODUCTION: In recent years, there has been an exponential increase in the number of studies aiming to understand the biology of exosomes, as well as other extracellular vesicles. However, classification of membrane vesicles and the appropriate protocols for their...

Cite
Crescitelli R, Lässer C, Szabó TG, et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013;2doi: 10.3402/jev.v2i0.20677.
Crescitelli, R., Lässer, C., Szabó, T. G., Kittel, A., Eldh, M., Dianzani, I., Buzás, E. I., & Lötvall, J. (2013). Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. Journal of extracellular vesicles, 2. https://doi.org/10.3402/jev.v2i0.20677
Crescitelli, Rossella, et al. "Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes." Journal of extracellular vesicles vol. 2 (2013). doi: https://doi.org/10.3402/jev.v2i0.20677
Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI, Lötvall J. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013 Sep 12;2. doi: 10.3402/jev.v2i0.20677. eCollection 2013. PMID: 24223256; PMCID: PMC3823106.
Copy Download .nbib Format: NLM
The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer.

Cancers

Pizzimenti S, Toaldo C, Pettazzoni P, Dianzani MU, Barrera G.
PMID: 24281073
Cancers (Basel). 2010 Mar 30;2(2):338-63. doi: 10.3390/cancers2020338.

Reacytive Oxygen Species (ROS) have long been considered to be involved in the initiation, progression and metastasis of cancer. However, accumulating evidence points to the benefical role of ROS. Moreover, ROS production, leading to apoptosis, is the mechanism by...

Cite
Pizzimenti S, Toaldo C, Pettazzoni P, et al. The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel). 2010;2(2):338-63doi: 10.3390/cancers2020338.
Pizzimenti, S., Toaldo, C., Pettazzoni, P., Dianzani, M. U., & Barrera, G. (2010). The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers, 2(2), 338-63. https://doi.org/10.3390/cancers2020338
Pizzimenti, Stefania, et al. "The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer." Cancers vol. 2,2 (2010): 338-63. doi: https://doi.org/10.3390/cancers2020338
Pizzimenti S, Toaldo C, Pettazzoni P, Dianzani MU, Barrera G. The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel). 2010 Mar 30;2(2):338-63. doi: 10.3390/cancers2020338. PMID: 24281073; PMCID: PMC3835081.
Copy Download .nbib Format: NLM
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.

PPAR research

Cerbone A, Toaldo C, Pizzimenti S, Pettazzoni P, Dianzani C, Minelli R, Ciamporcero E, Roma G, Dianzani MU, Canaparo R, Ferretti C, Barrera G.
PMID: 22619672
PPAR Res. 2012;2012:269751. doi: 10.1155/2012/269751. Epub 2012 Feb 29.

PPARαs are nuclear receptors highly expressed in colon cells. They can be activated by the fibrates (clofibrate, ciprofibrate etc.) used to treat hyperlipidemia. Since PPARα transcriptional activity can be negatively regulated by JNK, the inhibition of JNK activity could...

Cite
Cerbone A, Toaldo C, Pizzimenti S, et al. AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells. PPAR Res. 2012;2012:269751doi: 10.1155/2012/269751.
Cerbone, A., Toaldo, C., Pizzimenti, S., Pettazzoni, P., Dianzani, C., Minelli, R., Ciamporcero, E., Roma, G., Dianzani, M. U., Canaparo, R., Ferretti, C., & Barrera, G. (2012). AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells. PPAR research, 2012269751. https://doi.org/10.1155/2012/269751
Cerbone, Angelo, et al. "AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells." PPAR research vol. 2012 (2012): 269751. doi: https://doi.org/10.1155/2012/269751
Cerbone A, Toaldo C, Pizzimenti S, Pettazzoni P, Dianzani C, Minelli R, Ciamporcero E, Roma G, Dianzani MU, Canaparo R, Ferretti C, Barrera G. AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells. PPAR Res. 2012;2012:269751. doi: 10.1155/2012/269751. Epub 2012 Feb 29. PMID: 22619672; PMCID: PMC3349252.
Copy Download .nbib Format: NLM
Geometrical Bounds on Irreversibility in Open Quantum Systems.

Physical review letters

Mancino L, Cavina V, De Pasquale A, Sbroscia M, Booth RI, Roccia E, Gianani I, Giovannetti V, Barbieri M.
PMID: 30387653
Phys Rev Lett. 2018 Oct 19;121(16):160602. doi: 10.1103/PhysRevLett.121.160602.

The Clausius inequality has deep implications for reversibility and the arrow of time. Quantum theory is able to extend this result for closed systems by inspecting the trajectory of the density matrix on its manifold. Here we show that...

Cite
Mancino L, Cavina V, De Pasquale A, et al. Geometrical Bounds on Irreversibility in Open Quantum Systems. Phys Rev Lett. 2018;121(16):160602doi: 10.1103/PhysRevLett.121.160602.
Mancino, L., Cavina, V., De Pasquale, A., Sbroscia, M., Booth, R. I., Roccia, E., Gianani, I., Giovannetti, V., & Barbieri, M. (2018). Geometrical Bounds on Irreversibility in Open Quantum Systems. Physical review letters, 121(16), 160602. https://doi.org/10.1103/PhysRevLett.121.160602
Mancino, Luca, et al. "Geometrical Bounds on Irreversibility in Open Quantum Systems." Physical review letters vol. 121,16 (2018): 160602. doi: https://doi.org/10.1103/PhysRevLett.121.160602
Mancino L, Cavina V, De Pasquale A, Sbroscia M, Booth RI, Roccia E, Gianani I, Giovannetti V, Barbieri M. Geometrical Bounds on Irreversibility in Open Quantum Systems. Phys Rev Lett. 2018 Oct 19;121(16):160602. doi: 10.1103/PhysRevLett.121.160602. PMID: 30387653.
Copy Download .nbib Format: NLM
What Hong-Ou-Mandel interference says on two-photon frequency entanglement.

Scientific reports

Barbieri M, Roccia E, Mancino L, Sbroscia M, Gianani I, Sciarrino F.
PMID: 28775259
Sci Rep. 2017 Aug 03;7(1):7247. doi: 10.1038/s41598-017-07555-4.

Not much, in the end. Here we put forward some considerations on how Hong-Ou-Mandel interferometry provides signatures of frequency entanglement in the two-photon state produced by parametric down-conversion. We find that some quantitative information can be inferred in the...

Cite
Barbieri M, Roccia E, Mancino L, et al. What Hong-Ou-Mandel interference says on two-photon frequency entanglement. Sci Rep. 2017;7(1):7247doi: 10.1038/s41598-017-07555-4.
Barbieri, M., Roccia, E., Mancino, L., Sbroscia, M., Gianani, I., & Sciarrino, F. (2017). What Hong-Ou-Mandel interference says on two-photon frequency entanglement. Scientific reports, 7(1), 7247. https://doi.org/10.1038/s41598-017-07555-4
Barbieri, Marco, et al. "What Hong-Ou-Mandel interference says on two-photon frequency entanglement." Scientific reports vol. 7,1 (2017): 7247. doi: https://doi.org/10.1038/s41598-017-07555-4
Barbieri M, Roccia E, Mancino L, Sbroscia M, Gianani I, Sciarrino F. What Hong-Ou-Mandel interference says on two-photon frequency entanglement. Sci Rep. 2017 Aug 03;7(1):7247. doi: 10.1038/s41598-017-07555-4. PMID: 28775259; PMCID: PMC5543181.
Copy Download .nbib Format: NLM
Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model.

Brain sciences

Keller R, Chieregato S, Bari S, Castaldo R, Rutto F, Chiocchetti A, Dianzani U.
PMID: 32630229
Brain Sci. 2020 Jul 01;10(7). doi: 10.3390/brainsci10070416.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in communication and relational skills, associated with repetitive verbal and motor behaviors, restricted patterns of interest, need for a predictable and stable environment, and hypo- or hypersensitivity to...

Cite
Keller R, Chieregato S, Bari S, et al. Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model. Brain Sci. 2020;10(7)doi: 10.3390/brainsci10070416.
Keller, R., Chieregato, S., Bari, S., Castaldo, R., Rutto, F., Chiocchetti, A., & Dianzani, U. (2020). Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model. Brain sciences, 10(7), . https://doi.org/10.3390/brainsci10070416
Keller, Roberto, et al. "Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model." Brain sciences vol. 10,7 (2020). doi: https://doi.org/10.3390/brainsci10070416
Keller R, Chieregato S, Bari S, Castaldo R, Rutto F, Chiocchetti A, Dianzani U. Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model. Brain Sci. 2020 Jul 01;10(7). doi: 10.3390/brainsci10070416. PMID: 32630229; PMCID: PMC7407178.
Copy Download .nbib Format: NLM
Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution.

Nanomaterials (Basel, Switzerland)

Chirio D, Peira E, Dianzani C, Muntoni E, Gigliotti CL, Ferrara B, Sapino S, Chindamo G, Gallarate M.
PMID: 30744025
Nanomaterials (Basel). 2019 Feb 08;9(2). doi: 10.3390/nano9020230.

No abstract available.

Cite
Chirio D, Peira E, Dianzani C, et al. Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution. Nanomaterials (Basel). 2019;9(2)doi: 10.3390/nano9020230.
Chirio, D., Peira, E., Dianzani, C., Muntoni, E., Gigliotti, C. L., Ferrara, B., Sapino, S., Chindamo, G., & Gallarate, M. (2019). Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution. Nanomaterials (Basel, Switzerland), 9(2), . https://doi.org/10.3390/nano9020230
Chirio, Daniela, et al. "Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution." Nanomaterials (Basel, Switzerland) vol. 9,2 (2019). doi: https://doi.org/10.3390/nano9020230
Chirio D, Peira E, Dianzani C, Muntoni E, Gigliotti CL, Ferrara B, Sapino S, Chindamo G, Gallarate M. Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution. Nanomaterials (Basel). 2019 Feb 08;9(2). doi: 10.3390/nano9020230. PMID: 30744025; PMCID: PMC6410061.
Copy Download .nbib Format: NLM
Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.

BioMed research international

Bagnati M, Puricelli C, Bauce G, Basile M, Grigollo B, Prodam F, Dianzani U, Bellomo G, Rolla R.
PMID: 34901269
Biomed Res Int. 2021 Dec 02;2021:3508281. doi: 10.1155/2021/3508281. eCollection 2021.

BACKGROUND AND AIMS: Inflammatory, oxidative stress, and endothelial dysfunction play a key role in the pathogenesis of long-term cardiovascular complications in patients with diabetes. The present observational prospective study is aimed at evaluating the effects of micronutrients and phytochemicals...

Cite
Bagnati M, Puricelli C, Bauce G, et al. Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study. Biomed Res Int. 2021;2021:3508281doi: 10.1155/2021/3508281.
Bagnati, M., Puricelli, C., Bauce, G., Basile, M., Grigollo, B., Prodam, F., Dianzani, U., Bellomo, G., & Rolla, R. (2021). Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study. BioMed research international, 20213508281. https://doi.org/10.1155/2021/3508281
Bagnati, Marco, et al. "Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study." BioMed research international vol. 2021 (2021): 3508281. doi: https://doi.org/10.1155/2021/3508281
Bagnati M, Puricelli C, Bauce G, Basile M, Grigollo B, Prodam F, Dianzani U, Bellomo G, Rolla R. Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study. Biomed Res Int. 2021 Dec 02;2021:3508281. doi: 10.1155/2021/3508281. eCollection 2021. PMID: 34901269; PMCID: PMC8660183.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 87 entries